Search results for "Targeted Cancer Drugs"

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they have selected the "2026 Health...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its CDK7-inhibiting oncology candidate,...
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy.
Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors

Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors

A new type of cancer treatment delivered through the nose, rather than by conventional injection, is gaining...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development

Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development

The new drug development platform Pharmulator™ has officially made its debut on the international stage—not at a...

"Breast Cancer Diagnosis, It's Too Early to Give Up" A Doctor's Calm Comfort

"Many breast cancer patients struggle with the process of fighting the disease. This is likely due to the thought that...
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals

Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals

Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...